Phase II studies on docetaxel alone every third week, or...

Medical Oncology 2007 / 12 Vol. 24; Iss. 4

Phase II studies on docetaxel alone every third week, or weekly in combination with gemcitabine in patients with primary locally advanced, metastatic, or recurrent esophageal cancer

M. Albertsson, B. Johansson, S. Friesland, L. Kadar, H. Letocha, G. Frykholm, G. Wagenius
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
24
Language:
english
Pages:
6
DOI:
10.1007/s12032-007-0028-6
Date:
December, 2007
File:
PDF, 133 KB
english, 2007
Conversion to is in progress
Conversion to is failed